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The study presents the updated data on the multiple myeloma (MM) incidence in Ukrainian cleanup workers after the Chornobyl 
accident and their survival. The epidemiological analysis is based on the extended follow-up period to identify new MM cases for 
higher statistical power and to collect additional data on the disease course and outcome for the survival analysis. The objective 
of the study was to analyze the MM incidence and survival in Chornobyl cleanup workers in 1996–2013 in comparison with the 
national MM statistical data. Materials and Methods: A study cohort consisted of 152,520 male cleanup workers resided in one 
of 6 regions of Ukraine or Kyiv city and registered in the Ukrainian State Chornobyl Registry (SChR). The Cohort Database was 
linked to the Ukrainian National Cancer Registry (NCR) Database to identify MM cases and to analyze MM incidence in 1996–
2013. Standardized incidence ratios (SIR) for MM over the period 1996–2013 were calculated as compared to the general popu-
lation of Ukraine. A 10-year lag period (when incident cases are not considered radiation-related) was applied. One-year and 5-year 
cause-specific survival of MM cases were calculated as percentage of those who were alive correspondingly for 1 or 5 years after 
diagnosis among overall diagnosed. By the moment, the 5-year survival rate either for the sub-period 2008–2013 or for the whole 
study period 1996–2013 cannot be determined. Vital status data were updated according to the recent SChR and NCR informa-
tion. Results: 75 MM cases diagnosed in 1986–2013 were identified in the studied cohort. 69 of them were included to the incidence 
analysis considering a 10-year lag period. While the incidence over 15 years after the accident did not differ significantly from the 
corresponding rate in general population of Ukraine, a tendency to increase was seen in the period from 16 to 21 years after the 
accident, and significantly increased SIR estimate was revealed for 2008–2013 (SIR 1.86, 95% confidence interval (CI) 1.27–2.44). 
The highest incidence was detected in 2008–2013 among cohort members diagnosed over the age of 50 years mostly due to the 
significant excess among those aged 60–69 (SIR 2.46, 95% CI 1.32–3.59). Survival rates in cleanup workers were shown 
to be higher than in the general population of Ukraine (73.9% and up to 65.0%, respectively). Conclusions: SIR for the 2008–
2013 period, 22–27 years after the accident, demonstrated the significant excess of MM incidence among male cleanup workers. 
Survival of MM cases is higher in cleanup workers in comparison with that in general population. This article is a part of a Special 
Issue entitled “The Chornobyl Nuclear Accident: Thirty Years After”.
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Multiple myeloma �MM� represents a malignancy 
from mature B-cell lymphocytes that may appear after 
the exposure to ionizing radiation. The effect of ionizing 
radiation is still de�ata�le although some evidence was 
received from the studies of population groups irradia-
ted due to the accidents� professional or medical needs.
Potential causative role of ionizing radiation in MM in-
duction was shown in the mortality studies of survivors 
after A-�om�ing in Japan [�]� although incidence study 
among the Life Span Study cohort ��95������� did not 
confirm these findings [�]. However� the MM incidence 
was higher among nuclear industry workers than in the 
general population. The �5-country colla�orative study 
of cancer risk among radiation workers reported a�out 
a marginally significant association for MM [�]. Also the 
study completed �y IARC in �995 among nuclear wor-
kers from facilities in the USA� the UK and Canada found 
weak �ut statistically significant association �etween 
occupational exposure and the risk of MM �one-sided 
p value = �.���; 44 deaths� [4]. А positive association 
�etween MM and low level doses of external exposure 
increasing with the age at exposure was shown among 
nuclear workers at the US �epartment of Energy facili-
ties [5]. MM was in excess in the Hanford Nuclear Res-
ervation cohort [�]. A case-control study of MM risk and 
internal uranium dose among workers at the Oak Ridge 
Gaseous �iffusion Plant showed weak statistically sig-
nificant association [�]. In the French cohort of nuclear 
wor kers an excess of �orderline statistical significance 
for MM was o�served [�]. �espite the o�served healthy 
worker effect in general for MM there was an indication 
of an increasing trend in risk with external dose �p = �.���.
On the other hand� some recent studies in Czech 
uranium miners [9] and in patients treated with pelvic ra-
diotherapy [��] have shown no excess of MM. Highly ex-
posed due to treatment were shown to have higher risk 
of MM incidence although not significantly. In Ukraine 
the MM incidence in ��������� was �.���.� per 
������� population� it increased significantly with age 
and had non-homogenous time trends. The incidence 
of MM was higher in males than in females. First year 
mortality in newly diagnosed MM patients in Ukraine 
in ��������� decreased ranging from 4�.� to �4.�% 
with a su�stantially higher portion of deceased within 
Submitted: June 29, 2016. 
*Correspondence:  E-mail: bazyka@yahoo.com 
Abbreviations used: MM — multiple myeloma; NCR — National 
Cancer Registry; NRCRM — National Research Center for Radia-
tion Medicine; RBM — red bone marrow; SChR — State Chornobyl 
Registry; SIR — standardized incidence ratio.
Exp Oncol ����
��� 4� �������
��� Experimental Oncology ��� �������� ���� ��ecem�er�
� year among males. Correspondingly� �-year survival 
increased with time and ranged from 59.� to �5.4% [��].
After the Chorno�yl accident� hundreds of thou-
sands of cleanup workers �predominantly males� 
were irradiated while working in the territories around 
the nuclear power plant. Hematological malignancies 
were among the first expected outcomes in exposed 
population that motivated scientific community to initi-
ate widespread investigations.
The study on MM in a range of malignant hemato-
logical disorders in Chorno�yl cleanup workers pro-
vides an opportunity to verify dependencies explored 
earlier and to get additional data on MM appearance 
after low dose/dose rate radiation exposure.
The o�jective of the study was to analyze standar-
dized incidence ratio �SIR� of MM and survival in a co-
hort of male cleanup workers in �99������.
MATERIALS AND METHODS
The study cohort was assem�led �asing on the State 
Chorno�yl Registry �SChR� and consisted of �5��5�� male 
cleanup workers resided � o�lasts of Ukraine �Cherkassy� 
Chernihiv� �nipropetrovsk� �onetsk� Kharkiv� Kyiv� and 
Kyiv city. Periodically updated personal data �demo-
graphic information and results of annual health checks� 
were transferred from the SChR �ata�ase to the cohort 
file at the National Research Center for Radiation Medi-
cine �NRCRM� [��� ��]. The cohort includes males who 
were exposed in young or middle age predominantly. 
A�out ��% were younger than 4� at first exposure �mean 
age �4.5 years� �Ta�le ��.
Table 1. Main characteristics of the study cohort of Ukrainian liquidators 
and MM cases identified in this cohort in 1996–2013
Age group, 
years
Cohort under follow up, 
number of subjects, n (%)
MM cases,  
number of subjects, n (%)
Attained age 
at registration 
in the SChR
Age at first 
exposure
Attained age 
at registration 
in the SChR
Age at first 
exposure
< 30 21,226 (13.9) 43,358 (28.4) 5 (7.2) 8 (11.6)
30–39 55,448 (36.4) 62,866 (41.2) 20 (29.0) 32 (46.4)
40–49 42,220 (27.7) 25,238 (16.5) 21 (30.4) 21 (30.4)
50–59 21,953 (14.4) 8381 (5.5) 16 (23.2) 3 (4.3)
60–69 9666 (6.3) 773 (0.5) 7 (10.1) 0
≥ 70 1578 (1.0) 0 0 0
Unknown 429 (0.3) 11,899 (7.8) 0 5 (7.2)
Total 152,520 (100) 152,520 (100) 69 (100) 69 (100)
Mean age, 
years (± SD)
41.1 (± 11.1) 34.5 (± 8.8) 45.1 (± 10.9) 38.2 (± 0.9)
The study on MM among cleanup workers was initi-
ated within the framework of the joint U.S.-Ukrainian 
study on leukemia and other hematological disorders. 
At that time� data on patients with MM diagnosed in the 
period �9������� were identified �y search in local 
and state hematological departments. Further inves-
tigation was carried out �y the NRCRM group. The 
Cohort �ata�ase was linked to the Ukrainian National 
Cancer Registry �NCR� �ata�ase to identify MM cases 
diagnosed in the cohort in ���������.
Cases diagnosed �efore ���� were reviewed �y the 
International �iagnostic review panel and classified 
using the International Staging System [��]. For cases 
diagnosed in ��������� a validation procedure was 
performed using the medical records and pathology 
information o�tained from the NCR and reviewed 
�y the NRCRM experts.
Individual doses to red �one marrow �RBM� due 
to su�ject’s external exposure were reconstructed 
retrospectively using a time-and-motion RA�RUE 
method� which was developed for studies of the Chor-
no�yl accident consequences �y the international 
group of experts [�4]. We ta�ulated the demographic 
characteristics of verified MM cases and calculated 
crude rates as well as SIR for cleanup workers using 
the Ukrainian population statistics. We calculated 
trends in �- and 5-year survival for MM over the period 
from �99� to ����. To analyze at least �-year survival 
of patients we controlled the vital status of all identified 
cases until and over ���4.
Flow cytometry analysis was performed using �-la-
ser flow cytometer FACScali�ur �Becton �ickinson� 
USA� equipped with two lasers with excitation waves 
length of 4�� and ��5 nm. Whole �lood and �one 
marrow samples were stained using a standard B� pro-
cedure with com�inations of monoclonal anti�odies 
in two- and three-color assay. Panel of monoclonal 
anti�odies �all from Becton �ickinson� included: anti-
C�45/�4; anti-C�5/��/�9; anti-C���/�; anti-C���/
HLA�R; anti-C��/4/�; anti-C�45/5�/���; anti-
C��5/��; anti-C��9/��/��; anti-C��4/��. At �atch 
analysis the main B-cell su�sets were identified using 
the standard operational procedure. �uring �atch 
analysis three-color staining C�45/SSC graphs were 
used for setting lymphoid cell discrimination and at the 
next stage C�5�+���+ cell su�set was identified at two-
dimensional graph of C�45+SSC low gated cells.
RESULTS
�5 cases of MM were identified in the studied cohort 
in �9�������. � cases diagnosed in �9����995 were not 
included into analysis according to the applied ��-year 
lag period. SIR were calculated for �9 MM cases identi-
fied in the cohort during the follow-up period �99������. 
The demographic characteristics of these cases are 
given in Ta�le � together with the characteristics of the 
cohort. Mean attained age of the identified MM cases 
was 45.�� and it was 4�.� for cleanup workers at whole� 
a�out half of them were younger than 4� at time of regis-
tration in SChR. MM cases in average did not differ from 
the whole cohort mem�ers in age they started participa-
ting in cleanup �mean age at first exposure was ��.� and 
�4.5 years� correspondingly�. Su�jects first exposed 
�efore age 4� comprise respectively 5�.� and �9.9%. 
All �ut one cases were aged over 4� at the time of their 
diagnosis� median age at diagnosis was 5� years.
Clinical data for each case and �iological material 
samples �peripheral �lood� �one marrow or trepano-
�iopsy� for most of them were reviewed to confirm 
or clarify the diagnosis. Each of the identified cases 
diagnosed in �99������ has undergone the diagnosis 
verification procedure �y the independent �iagnostic 
Review Panel of qualified hematologists and hemato-
pathologists from the USA� France� the United Kingdom 
and Ukraine. The Panel’s consensus opinion was the 
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Review conclusion [�5]. High quality of MM diagnostics 
was recognized due to the high percentage of morpho-
logically confirmed MM cases in general population 
of Ukraine �9�%� and the confirmation rate achieved 
after the international diagnostic review of MM cases 
diagnosed in �99������� when 5 diagnoses of �5 re-
viewed cases were not confirmed� � of them just due 
to the lack of diagnostic material samples.
According to the performed analysis� MM incidence 
rate in the studied cohort of cleanup workers did not differ 
significantly from the corresponding rate in the general 
population of Ukraine for the period from �� to �5 years 
after the accident; a tendency to increase was demon-
strated in the period from �� to �� years after the ac-
cident� and significantly increased rates were revealed 
in ��������� �SIR �.��� 95% confidence interval �CI� 
�.����.44�� resulting in the excess during the whole 
study period �Ta�le ��. Persons diagnosed over the age 
of 5� were more vulnera�le mostly due to the significant 
excess in ��������� among those aged ����9 �SIR 
�.4�� 95% CI �.����.59�. Other su�groups of those older 
than 5� at diagnosis �5��59� and ≥ ��� haven’t shown any 
significant excess either during the whole study period 
or �y su�-periods.
Table 2. SIR for MM in the cohort of male cleanup workers in 1996–2013
Period of obser-
vation
Person-
years 
of obser-
vation
Number  
of cases
Crude 
rate 
per 
105
SIR (95% CI)ob-
served
expec-
ted
1996–2001 823,198 13 13.2 1.58 0.98 (0.45–1.52)
2002–2007 707,428 17 15.7 2.4 1.08 (0.57–1.60)
2008–2013 593,309 39 21.0 6.6 1.86 (1.27–2.44)
1996–2013 2,123,934 69 49.9 3.24 1.38 (1.06–1.71)
Age at diagnosis
< 50 983,091 10 9.7 1.02 1.03 (0.39–1.67)
≥ 50 1,140,843 59 37.9 5.17 1.56 (1.16–1.95)
The RBM doses due to external irradiation were re-
constructed for �� of �9 identified MM cases. �ose values 
were in the range from �.� to ��9�.� mGy. In � ��5.�%� 
cases the RBM doses were higher than ��� mGy. We plan 
to continue dose reconstruction for identified MM cases 
and for corresponding controls selected within the study 
cohort to analyze possi�le radiation risks.
As to identified cases �Ta�le ��� �-year survival indices 
were shown to �e higher than for those diagnosed in the 
general population of Ukraine ���.9% and up to �5% 
correspondingly� [��]. Greater survival in cleanup wor-
kers may result from �etter medical service in population 
groups affected �y the Chorno�yl accident comparing 
with the general population. One-year survival among the 
cases diagnosed �efore age 5� was expectedly higher 
than in older cases �ut not significantly.
By the end of o�servation period 4� ���.9%� pa-
tients were deceased �Ta�le ��. Analysis of the clinical 
course of the cases showed that the majority of the 
MM diagnoses were esta�lished at late stages of di-
sease with an involvement of the �one system� kidney� 
hemorrhagic syndrome due to the high level of a�nor-
mal proteins in the �lood and urine. All of these patients 
were diagnosed in �99������. Treatment strategies 
included monochemotherapy and radiotherapy.
Table 3. 1-year and 5-year survival of MM cases by sub-period of obser-
vation and age at diagnosis
Period of obser-
vation (cases di-
agnosis)
Number 
of cases  
(cases de-
ceased over 
2013, %)
Mean age 
(median 
age) at di-
agnosis, 
years
1-year sur-
vival, n (%)
5-year sur-
vival, n (%)
1996–2001 13 (92.3) 54 (57) 9 (69.2) 2 (15.4)
2002–2007 17 (76.5) 54 (53) 14 (82.4) 6 (35.3)
2008–2013 39 (43.6) 62 (62) 28 (71.8) n.d.*
1996–2013 69 (60.9) 58 (58) 51 (73.9) n.d.
Age at diagnosis
< 50 10 (70.0) 45 (46) 8 (80) n.d.
≥ 50 59 (59.3) 61 (60) 44 (74.6) n.d.
Note: *n.d. — non-determinable.
In the later period from ���� to ����� case diagnostics 
improved and patients were diagnosed at earlier stages 
of the disease. Proper diagnosis of solitary myeloma and 
MM without marked changes in �one tissue �ecame 
possi�le. MM diagnosis in � cases �efore ���� was 
esta�lished using classical clinical criteria �y the Inter-
national Review Group. A certain progress was achieved 
after implementation of flow cytometry. To investigate 
�one marrow and peripheral �lood clonal proliferative 
plasma cell pool the immunophenotyping was performed 
for �� cases. Typical MM cells were C���+ and C�5�+ 
with low expression of B-lineage antigens C��9� C���� 
C���� C��� and early antigens like C���. MM phenotype 
has to �e differentiated with the changes in monoclonal 
gammopathy of undetermined significance and NK-cell 
leukemia. For such cases C�5�/45/��� staining was 
implemented resulting in an increased quality of diagnos-
tics �Figure�. Treatment of MM �ecame more intensive with 
the use of modern protocols and su�sequent autologous 
stem cell transplantation in patients younger than �5 years. 
This approach can significantly improve the effective-
ness of treatment and patients’ quality of life. Elongation 
of MM cases survival is also associated with the advent 
of effective therapeutic drugs for this group of patients.
DISCUSSION
This study demonstrates increased incidence rates 
of MM in a cohort of Chorno�yl cleanup workers in a period 
up to �� years after the accident as compared to the gene-
ral population of Ukraine. Strength of this study is in the use 
of updated cohort ensuring statistical significance of the 
results [��]. These data are in conformity with previously 
o�tained data [��]� indicating an MM incidence increase 
with time since exposure. Our results are consistent 
in gene ral with conclusions o�tained in other long-term 
studies in nuclear workers� i.e. in a mortality study per-
formed in a pooled cohort of ��9��95 U.S. nuclear work-
ers at five nuclear facilities �Hanford site� Idaho National 
La�oratory� Oak Ridge National La�oratory� Savannah 
River site and at the Portsmouth Naval Shipyard�. The 
cohort was followed at the start of the workers �eginning 
their radiation work �at earliest� �etween �944 and �95�� 
through ���5. The dose dependent excess relative risk 
was shown for MM �ERR per �� mSv was �.9% �95% 
CI �.���9.5%� [��]. Unlike this study our aim was to reveal 
just incidence rates and survival during the study period. 
At the same time� planned reconstruction of RBM doses 
��� Experimental Oncology ��� �������� ���� ��ecem�er�
for identified cases and matched controls will provide the 
possi�ility of dose-dependent risk estimates.
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Figure. Expression of C���� and C�5� on MM cells: a� control 
staining; b� staining with C����-FITC and C�5�-PE
The uncertainties in our study as well as in other 
long-term studies are related to quality of diagnostic 
approaches used for case validation which are impro-
ving with time. Our group tried to reduce the influence 
of such factors at the first stage of the study ��9���
������ when the NCR data were not availa�le� �y invi-
ting the International Review Group for case diagnostic 
verification. Later cases were diagnosed �y the up-
to-date approach that ena�led one to differentiate 
�enign monoclonal B-lymphocytosis� unspecified 
monoclonal gammopathies� and other mature B-cell 
disorders. Such an approach is recommended �y other 
researchers [�����]. Hence� cases registered in the 
NCR were diagnosed with the up-to-date approaches. 
However� influence of differences in diagnostics quality 
on MM incidence in exposed and not-exposed groups 
remains unclear. This study hasn’t revealed significant 
differences in the MM natural course influencing timely 
diagnosis.
This study also demonstrated �etter survival rates 
for cleanup workers in comparison with the general 
population of Ukraine. This difference could �e related 
to the �etter health care and treatment opportunities 
in radiation exposed su�jects.
Our study provides the informative �ase for the 
consequent case-control study on dose dependent 
MM risk estimates. Next steps in our research will 
�e the following: incidence density sampling of the 
controls in the study cohort accounting for the attained 
age and region of residency; dose reconstruction for 
all identified cases and corresponding controls with 
RA�RUE method; applying the statistical models for 
MM risk evaluation.
CONCLUSIONS
The MM incidence in the male Chorno�yl cleanup 
workers in �99������ significantly exceeds the corres-
ponding rate in the general population of Ukraine with 
the highest SIR for the latest period of o�servation� 
���������. O�served MM incidence excess was due 
to the excess in those older than 5� at diagnosis mostly 
due to patients aged ����9. Survival of MM patients 
in the male cleanup workers cohort exceeds that in the 
general population of the corresponding gender and 
age. It tends to �e higher in the youngest men and 
decreases with increasing age. A case-control study 
needs to �e carried out to confirm dependencies 
in MM incidence on radiation dose if exist.
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